Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

12

Revenue 2014

Amgen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Amgen's 2013 sales performance.

Biocon backs away from biosimilar filings in Europe

Biocon backs away from biosimilar filings in Europe

In a statement, the company said it had been forced to withdraw its regulatory filings for biosimilar versions of Roche's breast cancer drug Herceptin (trastuzumab) and Amgen's long-acting ... Sales of Herceptin were around $7bn last year, while Amgen

Samsung deal with Takeda looks beyond biosimilars

Samsung deal with Takeda looks beyond biosimilars Samsung Bioepis has already been granted approvals for biosimilars of Amgen's Enbrel (etanercept), Johnson &Johnson's Remicade (infliximab) and Sanofi's Lantus (insulin glargine), and has filed for versions of

SMC gives green light for Amgen’s Kyprolis

SMC gives green light for Amgen’s Kyprolis SMC gives green light for Amgen’ s Kyprolis. The committee also gives verdict on three other products. ... Multiple myeloma patients - who have received at least one prior therapy - in Scotland will soon be able to access Amgen’s Kyprolis (carfilzomib

SMC gives green light for Amgen’s Kyprolis

SMC gives green light for Amgen’s Kyprolis SMC gives green light for Amgen’ s Kyprolis. The committee also gives verdict on three other products. ... Multiple myeloma patients - who have received at least one prior therapy - in Scotland will soon be able to access Amgen’s Kyprolis (carfilzomib

Audit exposes gaps in pharma's promises on trial transparency

Audit exposes gaps in pharma's promises on trial transparency transparency, followed by LEO Pharma, Takeda, Pfizer, Novartis, Novo Nordisk, Boehringer Ingelheim, Amgen, Merck &Co and AbbVie.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GEM Marketing Ltd

GEM, a small but perfectly formed integrated marketing agency servicing the pharmaceutical industry....

Latest intelligence

The_Pharma_Wars_Series.png
The Pharma Wars Series
The future galaxy is complex. Where markets are more competitive and customers more segmented, you’ve got to be smarter. But not only smarter, the Jedi today needs to be everywhere...
What pharma marketers can learn from growth hacking?
Growth hackers instinctively blend technical skills with creative thinking...
Medicines for Europe
The sound of silence puts the squeeze on generics and biosimilars
Medicines for Europe vows to get governments talking to realise potential...

Infographics